DNA methylation at enhancers identifies distinct breast cancer lineages.
about
"Same difference": comprehensive evaluation of four DNA methylation measurement platforms.DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.Applications of RNA Indexes for Precision Oncology in Breast CancerTET2 coactivates gene expression through demethylation of enhancers
P2860
DNA methylation at enhancers identifies distinct breast cancer lineages.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
DNA methylation at enhancers identifies distinct breast cancer lineages.
@en
DNA methylation at enhancers identifies distinct breast cancer lineages.
@nl
type
label
DNA methylation at enhancers identifies distinct breast cancer lineages.
@en
DNA methylation at enhancers identifies distinct breast cancer lineages.
@nl
prefLabel
DNA methylation at enhancers identifies distinct breast cancer lineages.
@en
DNA methylation at enhancers identifies distinct breast cancer lineages.
@nl
P2093
P2860
P50
P1476
DNA methylation at enhancers identifies distinct breast cancer lineages.
@en
P2093
Arnoldo Frigessi
Ellen Schlichting
Hari P Dhakal
Oslo Breast Cancer Research Consortium (OSBREAC)
Shixiong Wang
P2860
P2888
P356
10.1038/S41467-017-00510-X
P407
P50
P577
2017-11-09T00:00:00Z